Angelini Ventures
Overview
Angelini Ventures is the venture capital arm of Angelini Industries funded with a €300 million capital commitment to build and invest in companies that develop innovative ideas and solutions in biotec…
Investment Focus
- Innovative solutions in biotechnology, digital health, and life sciences
- Focus on brain health and consumer segments such as women, children, and the elderly
- Early-stage companies with potential to disrupt traditional healthcare models
Portfolio Companies
Reach Angelini Ventures directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Angelini Ventures
What sectors does Angelini Ventures invest in?
Angelini Ventures invests in HealthTech, Life Sciences, Digital Health, Pharmaceuticals, Medical Devices and Diagnostics, and is based in Italy. Angelini Ventures is listed as a corporate vc in the ConnectSafely investor database.
What stage does Angelini Ventures invest at?
Angelini Ventures backs companies at Pre-Seed, Seed and Early Stage, writing cheques of 1.5M - 3M.
Which regions does Angelini Ventures invest in?
Angelini Ventures invests across United States, United Kingdom, Canada, Germany, Singapore and France.
What companies has Angelini Ventures invested in?
Angelini Ventures's portfolio includes Argobio, Angelini Lumira Biosciences Fund, Pretzel Therapeutics, Nuevocor and Serenis.
How do I contact Angelini Ventures?
Angelini Ventures's contact details — including phone and LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of the team.
Last updated · Source: ConnectSafely investor database
